Abstract:Yingfan Chen, 1, 2, &ast Zhenhui Wu, 3, &ast Shaodan Li, 2 Qi Chen, 2 Liang Wang, 2 Xiaorong Qi, 1 Chujiao Tian, 1 Minghui Yang 2 1 Medical School of Chinese People's Liberation Army, Beijing, People's Republic of China; 2 Department of Traditional Chinese Medicine, the Six Medical Center of Chinese People's Liberation Army General Hospital, Beijing, People's Republic of China; 3 College of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang, People's Republic of China &astThese authors contributed equally to this work Correspondence: Minghui Yang, Department of Traditional Chinese Medicine, the Six Medical Center, Chinese People's Liberation Army General Hospital, 6 Fucheng Road, Beijing, 100048, People's Republic of China, Tel +86-10-66939651, Email Methods: Related studies on PD and ferroptosis were searched in Web of Science Core Collection (WOSCC) from inception to 2023. VOSviewer, CiteSpace, RStudio, and Scimago Graphica were employed as bibliometric analysis tools to generate network maps about the collaborations between authors, countries, and institutions and to visualize the co-occurrence and trends of co-cited references and keywords. Results: A total of 160 original articles and reviews related to PD and ferroptosis were retrieved, produced by from 958 authors from 162 institutions. Devos David was the most prolific author, with 9 articles. China and the University of Melbourne had leading positions in publication volume with 84 and 12 publications, respectively. Current hot topics focus on excavating potential new targets for treating PD based on ferroptosis by gaining insight into specific molecular mechanisms, including iron metabolism disorders, lipid peroxidation, and imbalanced antioxidant regulation. Clinical studies aimed at treating PD by targeting ferroptosis remain in their preliminary stages. Conclusion: A continued increase was shown in the literature within the related field over the past decade. The current study suggested active collaborations among authors, countries, and institutions. Research into the pathogenesis and treatment of PD based on ferroptosis has remained a prominent topic in the field in recent years, indicating that ferroptosis-targeted therapy is a potential approach to halting the progression of PD. Keywords: Parkinson's disease, ferroptosis, bibliometric analysis, iron accumulation, alpha-synuclein, mitochondrial dysfunction, oxidative stress, lipid peroxidation Parkinson's disease (PD) is the second most common central neurodegenerative disorder globally, 1 with the fastest-growing prevalence and disability rate. 2 By 2040, more than 12 million PD patients are predicted worldwide. 3 Cardinal motor symptoms, including bradykinesia, rigidity, and tremor, are of crucial importance in the accurate diagnosis of PD, and non-motor manifestations such as constipation, depression, anosmia, cognitive decline, and sleep disorders are prominent during the disease course. 4 The etiology and pathogenesis of PD remain unclear, while compelling evidence suggests that complex interactions between genetic, environmental, and age factors determine the risk and progression of PD, 5 and various mechanisms, such as oxidative stress (OS), neuroinflammation, and mitochondrial dysfunction, are intimately involved in pathophysiological development. The gradual degeneration of dopaminergic neurons in the substantia nigra (SN), along with abnormally aggregated α-synuclein (α-syn) forming Lewy bodies, are the pathological hallmarks of PD. 6 Although the current dopamine-based pharmacological therapies can alleviate motor symptoms in early-stage patients, there is a lack of effective neuroprotective treatment methods to prevent PD from progressively deteriorating. Therefore, investigating the underlying mechanisms of PD to explore novel targets and develop the next generation of therapies is urgently needed. Ferroptosis, a newly proposed cell death pathway characterized by iron-dependent reactive oxygen species (ROS) accumulation and lipid peroxidation of polyunsaturated fatty acids (PUFAs) present in plasma membranes, has been found to be a key player in the pathomechanism of PD and has gained the spotlight. 7 Recent studies have increasingly indicated that the principal features or triggering factors of ferroptosis, including iron ion imbalance, reduced glutathione levels, lipid peroxidation, DJ-1 depletion, and coenzyme Q10 (CoQ 10) decline, are consistent with the pathological features observed in PD, 8–14 suggesting a strong link between ferroptosis and the development of PD -Abstract Truncated-

Mapping the Research of Ferroptosis in Parkinson's Disease from 2013 to 2023: A Scientometric Review